Oligonucleotide therapeutics: a prospectus
- PMID: 8495103
- DOI: 10.1089/ard.1993.3.1
Oligonucleotide therapeutics: a prospectus
Similar articles
-
[Oligonucleotide therapeutics].Nihon Rinsho. 2012 Nov;70 Suppl 8:393-7. Nihon Rinsho. 2012. PMID: 23513872 Japanese. No abstract available.
-
[Oligonucleotide therapeutics - an emerging novel class of compounds].Wien Med Wochenschr. 2006 Sep;156(17-18):481-7. doi: 10.1007/s10354-006-0331-4. Wien Med Wochenschr. 2006. PMID: 17041803 Review. German.
-
Oligonucleotide therapeutics.Trends Biotechnol. 1992 Mar;10(3):87-91. doi: 10.1016/0167-7799(92)90180-4. Trends Biotechnol. 1992. PMID: 1371926 Review.
-
Nusinersen, an antisense oligonucleotide drug for spinal muscular atrophy.Nat Neurosci. 2017 Apr;20(4):497-499. doi: 10.1038/nn.4508. Epub 2017 Feb 13. Nat Neurosci. 2017. PMID: 28192393 Review. No abstract available.
-
Liver as a target for oligonucleotide therapeutics.J Hepatol. 2013 Dec;59(6):1354-9. doi: 10.1016/j.jhep.2013.05.045. Epub 2013 Jun 12. J Hepatol. 2013. PMID: 23770039
Cited by
-
Antisense oncogene and tumor suppressor gene therapy of cancer.J Mol Med (Berl). 1996 Apr;74(4):191-204. doi: 10.1007/BF00204749. J Mol Med (Berl). 1996. PMID: 8740650 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources